Transient receptor potential (TRP) channels as potential drug targets in respiratory disease

Cell Calcium

Volumn 33, Issue 5-6, 2003, Pages 551-558

  Li, Su ^a   Westwick, John ^a   Poll, Chris ^a  

^a Novartis Institutes for Biomedical Research   (United Kingdom)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Macrophages; ROCC; T lymphocytes; TRP

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ANTIINFLAMMATORY AGENT; CALCIUM CHANNEL; CALCIUM ION; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; MEMBRANE PROTEIN; MENTHOL; RESPIRATORY TRACT AGENT; THAPSIGARGIN; TRANSIENT RECEPTOR POTENTIAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BRONCHOSPASM; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CELL TYPE; CHANNEL GATING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG MECHANISM; DRUG TARGETING; ELECTRIC POTENTIAL; HUMAN; ION PERMEABILITY; LYMPHOCYTE; MACROPHAGE; MEMBRANE ELECTROPHYSIOLOGY; MOLECULAR DYNAMICS; NERVE CELL; NEUROLOGIC DISEASE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER;

EID: 0038311743     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4160(03)00060-5     Document Type: Article

References (79)

1. C.J. Murray, A.D. Lopez, Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study, Lancet 349 (1997) 1498-1504.
2. J.K. Peat, J. Li, Reversing the trend: reducing the prevalence of asthma, J. Allergy Clin. Immunol. 103 (1999) 1-10.
3. P.J. Barnes, Chronic obstructive pulmonary disease: new opportunities for drug development, Trends Pharmacol. Sci. 19 (1998) 415-423.
4. P.J. Barnes, New treatments for COPD, Nat. Rev. Drug Discov. 1 (2002) 437-446.
5. O.M. Kon, A.B. Kay, T cells and chronic asthma, Int. Arch. Allergy Immunol. 118 (1999) 133-135.
6. Q. Hamid, M. Azzawi, S. Ying, et al., Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma, J. Clin. Invest. 87 (1991) 1541-1546.
7. M. Humbert, S.R. Durham, S. Ying, et al., IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity, Am. J. Respir. Crit. Care Med. 154 (1996) 1497-1504.
8. M. Azzawi, B. Bradley, RK. Jeffery, et al., Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma, Am, Rev. Respir. Dis. 142 (1990) 1407-1413.
9. P.K. Jeffery, Structural and inflammatory changes in COPD: a comparison with asthma, Thorax 53 (1998) 129-136.
10. C. Walker, E. Bode, L. Boer, T.T. Hansel, K. Blaser, J.C. Virchow Jr., Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage, Am. Rev. Respir. Dis. 146 (1992) 109-115.
11. G.J. Gleich, C.R. Adolphson, The eosinophilic leukocyte: structure and function, Adv. Immunol. 39 (1986) 177-253.
12. A.J. Wardlaw, R. Moqbel, A.B. Kay, Eosinophils: biology and role in disease, Adv. Immunol. 60 (1995) 151-266.
13. S.D. Shapiro, Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease, Am. J. Respir. Crit. Care Med. 150 (1994) S160-SI64.
14. J.A. Nadel, K. Takeyama, Mechanisms of hypersecretion in acute asthma, proposed cause of death, and novel therapy, Pediatr. Pulmonol. Suppl. 18 (1999) 54-55.
15. V.M. Keatings, P.D. Collins, D.M. Scott, P.J. Barnes, Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma, Am. J. Respir. Crit. Care Med. 153 (1996) 530-534.
16. R. Finkelstein, R.S. Fraser, H. Ghezzo, M.G. Cosio, Alveolar inflammation and its relation to emphysema in smokers, Am. J. Respir. Crit. Care Med. 152 (1995) 1666-1672.
17. A. Di Stefano, G. Turato, P. Maestrelli, et al., Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa, Am. J. Respir. Crit. Care Med. 153 (1996) 629-632.
18. T.C. O'Shaughnessy, T. Ansari, N.C. Barnes, P.K. Jeffery, Inflammatory cells in the airway surface epithelium of smokers with and without bronchitic airflow obstruction, Eur. Respir. J. 9 (Suppl 23) (1996) 14S.
19. T.C. O'Shaughnessy, T.W. Ansari, N.C. Barnes, P.K. Jeffery, Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1, Am. J. Respir. Crit. Care Med. 155 (1997) 852-857.
20. M. Saetta, A. Di Stefano, G. Turato, et al., CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 157 (1998) 822-826.
21. P.J. Barnes, Mechanisms in COPD: differences from asthma, Chest 117 (2000) 10S-14S.
22. 2+ influx channels in leukocytes: a therapeutic target? Trends Pharmacol. Sci. 23 (2002) 63-70.
23. I. Rodger, Drugs affecting calcium ions in airway smooth muscle, in: P.J. Barnes (Ed.), New Drugs for Asthma, IBC publications, London, 1989, pp. 455-456.
24. R.K. Murray, M.I. Kotlikoff, Receptor-activated calcium influx in human airway smooth muscle cells, J. Physiol. 435 (1991) 123-144.
25. I. Gorenne, C. Labat, J.P. Gascard, X. Norel, N. Nashashibi, C. Brink, Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry, J. Pharmacol. Exp. Ther. 284 (1998) 549-552.
26. V.A. Snetkov, K.J. Hapgood, C.G. McVicker, T.H. Lee, J.P. Ward, Mechanisms of leukotriene D4-induced constriction in human small bronchioles, Br. J. Pharmacol. 133 (2001) 243-252.
27. 4, Fundam. Clin. Pharmacol. 1 (1987) 433-444.
28. 2+ release in agonist-induced contractions in guinea pig trachea, Am. J. Physiol. Lung Cell Mol. Physiol. 266 (1994) L620-L627.
29. H. Oonuma, T. Nakajima, T. Nagata, et al., Endothelin-1 is a potent activator of nonselective cation currents in human bronchial smooth muscle cells, Am. J. Respir. Cell Mol. Biol. 23 (2000) 213-221.
30. D.E. Clapham, L.W. Runnels, C. Strubing, The TRP ion channel family, Nat. Rev. Neurosci. 2 (2001) 387-396.
31. 2+ entry in bronchial contraction and remodeling, J. Appl. Physiol. 92 (2002) 1594-1602.
32. H.L. Ong, J. Chen, T. Chataway, et al., Specific detection of the endogenous transient receptor potential (TRP)-1 protein in liver and airway smooth muscle cells using immunoprecipitation and Western-blot analysis, Biochem. J. 364 (2002) 641-648.
33. R.L. Corteling, S.W. Li, A. Aitken, C.T. Poll, J. Westwick, I.P. Hall, Transient receptor potential (TPP) expression in human airway smooth muscle cells, Am. J. Respir. Crit. Care Med. 163 (5) (2001) A780.
34. 2+-permeable cation channel, Circ. Res. 88 (2001) 325-332.
35. D.G. Welsh, A.D. Morielli, M.T. Nelson, J.E. Brayden, Transient receptor potential channels regulate myogenic tone of resistance arteries, Circ. Res. 90 (2002) 248-250.
36. 2+ channel ECaC1, Br. J. Pharmacol. 134 (2001) 453-462.
37. J. Cui, J.S. Bian, A. Kagan, T.V. McDonald, CaT1 contributes to the store-operated calcium current in Jurkat T-lymphocytes, J. Biol. Chem. 277 (2002) 47175-47183.
38. M. Hoth, R. Penner, Depletion of intracellular calcium stores activates a calcium current in mast cells, Nature 355 (1992) 353-356.
39. R.S. Lewis, Calcium signaling mechanisms in T lymphocytes, Annu. Rev. Immunol. 19 (2001) 497-521.
40. 2+ availability involved in antigen-induced airway hyperresponsiveness in rats, Eur. J. Pharmacol. 278 (1995) 79-82.
41. M. Kanzaki, Y.Q. Zhang, H. Mashima, L. Li, H. Shibata, I. Kojima, Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I, Nat. Cell Biol. 1 (1999) 165-170.
42. R.R. Ji, T.A. Samad, S.X. Jin, R. Schmoll, C.J. Woolf, p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia, Neuron 36 (2002) 57-68.
43. T. Higenbottam, Chronic cough and the cough reflex in common lung diseases, Pulm. Pharmacol. Ther. 15 (2002) 241-247.
44. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, D. Julius, The capsaicin receptor: a heat-activated ion channel in the pain pathway, Nature 389 (1997) 816-824.
45. A. Szallasi, C. Goso, S. Manzini, Resiniferatoxin binding to vanilloid receptors in guinea pig and human airways, Am. J. Respir. Crit. Care Med. 152 (1995) 59-63.
46. G.J. Michael, J.V. Priestley, Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy, J. Neurosci. 19 (1999) 1844-1854.
47. D.R. Bergren, Enhanced lung C-fiber responsiveness in sensitized adult guinea pigs exposed to chronic tobacco smoke, J. Appl. Physiol. 91 (2001) 1645-1654.
48. Y. Jia, R.L. McLeod, X. Wang, L.E. Parra, R.W. Egan, J.A. Hey, Anandamide induces cough in conscious guinea-pigs through VR1 receptors, Br. J. Pharmacol. 137 (2002) 831-836.
49. M.J. Caterina, A. Leffler, A.B. Malmberg, et al., Impaired nociception and pain sensation in mice lacking the capsaicin receptor, Science 288 (2000) 306-313.
50. S.W. Hwang, U. Oh, Hot channels in airways: pharmacology of the vanilloid receptor, Curr. Opin. Pharmacol. 2 (2002) 235-242.
51. A.M. Peier, A. Moqrich, A.C. Hergarden, et al., A TRP channel that senses cold stimuli and menthol, Cell 108 (2002) 705-715.
52. D.D. McKemy, W.M. Neuhausser, D. Julius, Identification of a cold receptor reveals a general role for TRP channels in thermosensation, Nature 416 (2002) 52-58.
53. R. Eccles, Menthol and related cooling compounds, J. Pharm. Pharmacol. 46 (1994) 618-630.
54. C.E. Wright, E.A. Laude, T.J. Grattan, A.H. Morice, Capsaicin and neurokinin A-induced bronchoconstriction in the anaesthetised guinea-pig: evidence for a direct action of menthol on isolated bronchial smooth muscle, Br. J. Pharmacol. 121 (1997) 1645-1650.
55. R.L. Corteling, S.W. Li, C.T. Poll, H. Danahay, I.P. Hall, Expression of TRP (transient receptor potential) homologs in cultured human bronchial epithelium, Am. J. Respir. Crit. Care Med. 165 (8) (2002) A69.
56. 2+ reabsorption in the distal nephron, Annu. Rev. Physiol. 64 (2002) 529-549.
57. B.B. Singh, C.Y. Zheng, X.B. Liu, et al., Trp1-dependent enhancement of salivary gland fluid secretion: role of store-operated calcium entry, FASEB J. 15 (2001) 1652-1654.
58. 2+-dependent mechanism in canine airway epithelium, Br. J. Pharmacol. 112 (1994) 571-575.
59. L. Tsavaler, M.H. Shapero, S. Morkowski, R. Laus, Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins, Cancer Res. 61 (2001) 3760-3769.
60. 2+ in epithelial cells, Cell Regul. 1 (1990) 585-596.
61. + channel mediates regulatory volume decrease response in a human bronchial epithelial cell line, Am. J. Physiol. Cell Physiol. 283 (2002) C1705-C1714.
62. N.S. Delany, M. Hurle, P. Facer, et al., Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2, Physiol. Genomics 4 (2001) 165-174.
63. Y.K. Kim, E.R. Dirksen, M.J. Sanderson, Stretch-activated channels in airway epithelial cells, Am. J. Physiol. 265 (1993) C1306-C1318.
64. 2+-entry in polarized human bronchial and colonic epithelial cells, Cell Calcium 26 (1999) 253-260.
65. 2+ influx in well-differentiated human bronchial epithelial cells, Br. J. Pharmacol. (2003) in press.
66. E. Wehage, J. Eisfeld, I. Heiner, E. Jungling, C. Zitt, A. Luckhoff, Activation of the Cation Channel Long Transient Receptor Potential Channel 2 (LTRPC2) by Hydrogen Peroxide. A splice variant reveals a mode of action independent of ADP-ribose, J. Biol. Chem. 277 (2002) 23150-23156.
67. 2+ influx system mediated by LTRPC2, Science 293 (2001) 1327-1330.
68. 2+ influx in differentiating human stem cells and platelets, Biochim. Biophys. Acta 1539 (2001) 243-255.
69. 2+ release from endoplasmic reticulum in B lymphocytes, J. Exp. Med. 195 (2002) 673-681.
70. A. Gamberucci, E. Giurisato, P. Pizzo, et al., Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products, Biochem. J. 364 (2002) 245-254.
71. J.E. Merritt, W.P. Armstrong, C.D. Benham, et al., SK&F 96365, a novel inhibitor of receptor-mediated calcium entry, Biochem. J. 271 (1990) 515-522.
72. K. Itagaki, K.B. Kannan, D.H. Livingston, E.A. Deitch, Z. Fekete, C.J. Hauser, Store-operated calcium entry in human neutrophils reflects multiple contributions from independently regulated pathways, J. Immunol. 168 (2002) 4063-4069.
73. R.L. Garcia, W.P. Schilling, Differential Expression of Mammalian TRP Homologues across Tissues and Cell Lines, Biochem. Biophys. Res. Commun. 239 (1997) 279-283.
74. L. Yue, J.B. Peng, M.A. Hediger, D.E. Clapham, CaT1 manifests the pore properties of the calcium-release-activated calcium channel, Nature 410 (2001) 705-709.
75. CRAC and the Mg-nucleotide-regulated metal ion current MagNuM, J. Physiol. 539.2 (2002) 445-458.
76. 2+-inhibited cation (MIC) channels, J. Gen. Physiol. 119 (5 ) (2002) 487-507.
77. M.J. Nadler, M.C. Hermosura, K. Inabe, et al., LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability, Nature 411 (2001) 590-595.
78. L.W. Runnels, L. Yue, D.E. Clapham, The TRPM7 channel is inactivated by PIP(2) hydrolysis, Nat. Cell Biol. 4 (2002) 329-336.
79. 2+ channel in trp4 knockout mice interferes with increase in microvascular endothelial permeability, FASEB J. 91 (1)